Hanlin Wang

10PUBLICATIONS
29CO-AUTHORS
Molecular targetsMedical biochemistry - proteins and peptides (incl. medical proteomics)Medical biochemistry - amino acids and metabolitesMedical infection agents (incl. prions)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 10, 2026
A first-in-class pulsatile FXR agonist for bile-acid-related liver diseases.

|Mar 24, 2026
Potent and selective LSD1 inhibitor DC551040 reveals a promising combination therapy for AML with insight into epigenetic dysregulation.

Jiang Wang, Hanlin Wang, Runhua Du

|Apr 17, 2025
ZBTB17/MIZ1 promotes peroxisome biogenesis by transcriptional regulation of PEX13.

Hongqin Liu, Xi Chen, Hanlin Wang

|Feb 18, 2025
Macrophage SUCLA2 coupled glutaminolysis manipulates obesity through AMPK.

Chang Peng, Haowen Jiang, Liya Jing

|Apr 05, 2023
Targeting C/EBPα overcomes primary resistance and improves the efficacy of FLT3 inhibitors in acute myeloid leukaemia.

Hanlin Wang, Guanghao Luo, Xiaobei Hu

|Mar 05, 2023
Phosphorylation of PHF2 by AMPK releases the repressive H3K9me2 and inhibits cancer metastasis.

Ying Dong, Hao Hu, Xuan Zhang

Pageof 2

Frequent Collaborators

6 joint publications

Jia Li

3 joint publications

Yi Zang

2 joint publications

Minjia Tan

2 joint publications

Yubo Zhou